- Drug Approvals and Databases | FDA
Novel Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products Drug and Biologic Approval and IND Activity Reports This Week's Drug Approvals Drug Trials Snapshots
- Warning Letters | FDA
Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the
- FDA Dashboards - Inspections
FDA does not issue CGMP certificates at the conclusion of an inspection Instead, this dashboard provides the outcomes, including classification and other details, of a firm’s most recent inspection
- Novel Drug Approvals for 2025 | FDA
To see the FDA-approved conditions of use [e g , indication (s), population (s), dosing regimen (s)] for each of these products, please see the most recently approved Prescribing Information (or
- Inspection Classification Database | FDA
The Food and Drug Administration (FDA) inspects and assesses regulated facilities to determine a firm's compliance with applicable laws and regulations, such as the Food, Drug, and Cosmetic Act
- Nutrition, Food Labeling, and Critical Foods | FDA
These FDA web pages address the labeling requirements for foods under the Federal Food, Drug, and Cosmetic Act and its amendments
- FDA Issues Warning About Imported Cookware That May Leach Lead: August
The U S Food and Drug Administration (FDA) is warning retailers and consumers not to sell or use certain imported cookware that may leach significant levels of lead (Pb) into food
- Compounding: Inspections, Recalls, and other Action | FDA
See FDA's Enforcement Report to Search Recalls, Including Compounded Drug Products Inspections, Recalls, and Other Actions with Respect to Firms that Engage in Animal Drug Compounding
|